fashion -WSS

fashion

author：hotspot 2025-10-01 02:28:22 - browse：3

the White House and the lawn in front of it shows behind a railing – coverage from STAT — Mark Wilson/Getty Images

President Biden’s executive order on artificial intelligence amounts to a giant course correction in health care. The actions taken in response could dramatically reshape how AI is used — and how much it costs — in areas from drug research to hospital care.

The order, released in full detail late Monday, calls for two elements of AI oversight that are currently nonexistent in health care: a policy, or independent body, that would test and assure the quality of AI tools, and a “central tracking repository” to report clinical errors associated with the use of the technology.

AI standards bodies in health care have previously pitched both ideas, but throwing the weight of the federal government behind them is more likely to bring them to fruition. Biden’s orders all require action before next fall’s election, a timeline designed to build momentum behind regulations that may be harder for a successor with different ideas to reverse.

Get unlimited access to award-winning journalism and exclusive events.

Subscribe Log In

Previous article： Dobbs anniversary: the lost opportunity of abortion as health care
Next article： Congress: Prevent baby formula shortages by passing a new bill

WSS

Disappointing trial forces Pfizer to pivot on obesity medicine plans

How to pay for weight loss drugs and save Medicare

Pediatric cancer treatments threatened by a new FDA policy

As biotech industry slumps, bioscience job market is upside down

The world needs the new pandemic treaty

Pharma’s losing bet in New Jersey

explore

fashion

explore

Affirmative action in medical school literally saved lives

Is mRNA technology the right fit for flu shots? Experts aren’t so sure

The cancer drug shortage isn’t new — and neither are the solutions

J&J reports mixed data on next

Activists slam private health insurers over coverage restrictions

Ozempic cut risk of death in diabetes patients with chronic kidney disease

Affirmative action in medical school literally saved lives

Lawsuit challenges CMS nursing home minimum staffing rule

Duchenne breakthrough therapy leaves behind pioneering families

Asahi Kasei to buy Calliditas, picking up kidney disease drug

knowledge

Hospitals need to get ahead of regulations on climate change

30 years of 'Listening to Prozac'

What don’t we know about an Alzheimer’s drug side effect?

Beyond aggravation: Constipation is an American epidemic

Why some fertility treatments produce more boy babies

Organ aging and disease risk measured by new blood test

focus

leisure time

entertainment

Wikipedia